News | November 10, 2024
Henkel, Covestro and Quad Industries collaborate for advanced medical wearables based on printed electronics
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Neuland Laboratories has reported total income of Rs. 315.17 crores during the period ended September 30, 2024
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Dr. Reddy's Laboratories has reported total income of Rs. 8,016.2 crores during the period ended September 30, 2024
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide
This is in pursuance to the announcement made in the Union Budget for the year 2024-25 exempting these three anti-cancer medicines from customs duty
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Subscribe To Our Newsletter & Stay Updated
